KalVista pill reduces swelling symptoms caused by genetic disease, achieving goal of late-stage study February 23, 2024
Weeks after $213M launch, Tome acquires a Berkeley gene editing startup for DNA ligase technology January 2, 2024
Big Pharma-backed Sitryx Locks an Additional $39M in a Series A Raise to Advance its Immunometabolic Pipeline September 28, 2023
Phil Vickers talks new role as head of Longwood’s Solu after Faze shutdown; Regeneron CFO to retire in February September 15, 2023
